Showing 6461-6470 of 10618 results for "".
- Addressing OUD Stigma: Impactful Strategies in Pharmacy Educationhttps://reachmd.com/news/addressing-oud-stigma-impactful-strategies-in-pharmacy-education/2485073/The Let's Talk Stigma program underwent a mixed-methods evaluation combining pre–post surveys, attendance logs, and qualitative interviews to assess reach,
- Impact of Basal Luteinizing Hormone Levels on IVF Outcomes in PCOS: Clinical Insightshttps://reachmd.com/news/impact-of-basal-luteinizing-hormone-levels-on-ivf-outcomes-in-pcos-clinical-insights/2485076/Elevated basal LH in women with PCOS preserves metaphase II oocyte yield and embryo quality during IVF/ICSI but amplifies ovarian responsiveness and OHSS risk — making basal LH a useful pre-cycle risk signal to guide stimulation protocol choice and mitigation planning.
- Exploring Sustainable Device Energy Management in Surgeryhttps://reachmd.com/news/exploring-sustainable-device-energy-management-in-surgery/2485089/Canadian perioperative team implemented an ultrasound power-down protocol<
- Orelabrutinib: A Leap Forward in SLE Therapy from Phase IIb to Phase IIIhttps://reachmd.com/news/orelabrutinib-a-leap-forward-in-sle-therapy-from-phase-iib-to-phase-iii/2485087/Orelabrutinib met its primary endpoint in a Phase IIb study
- Augmented Reality in Hepatic Surgery: Evaluating its Efficacy and Safetyhttps://reachmd.com/news/augmented-reality-in-hepatic-surgery-evaluating-its-efficacy-and-safety/2485058/A new systematic review and meta-analysis shows augmented reality–guided hepatic resection reduces perioperative blood loss and transfusion requirements compared with convent
- Surgical Techniques in ACL Reconstruction: Balancing Return-to-Play Timing and Long-Term Outcomeshttps://reachmd.com/news/acl-reconstruction-return-to-play-outcomes/2485027/A new study shows that return-to-sport (RTS) timing matters for longer-term athlete outcomes; among soccer players after ACL reconstruction, earlier return was associated wit
- FDA Clears Cutera truFlex® for Muscle Rehab, Recovery, and Post-Surgical Usehttps://reachmd.com/news/fda-clears-cutera-truflex-for-muscle-rehab-recovery-and-post-surgical-use/2485023/Cutera, Inc. has announced that its truFlex® muscle stimulation system has received expanded US Food and Drug Administration (FDA) clearances for use in rehabilitation, recovery, and muscle wellness applications. Originally cleared for aesthetic body contouring, the system can now be used to stre
- High-Dose Rifampicin Shows No Survival Benefits in Tuberculous Meningitis: Clinical Implicationshttps://reachmd.com/news/high-dose-rifampicin-shows-no-survival-benefits-in-tuberculous-meningitis-clinical-implications/2484988/Radboud University Medical Center and international partners tested whether adding a higher oral rifampicin dose to standard four-drug therapy would reduce deaths in adults with tuberculous meningitis in the randomized
- Vixarelimab Shows Dose-Dependent Efficacy in Prurigo Nodularis Phase 2b Trialhttps://reachmd.com/news/vixarelimab-shows-dose-dependent-efficacy-in-prurigo-nodularis-phase-2b-trial/2484982/Vixarelimab demonstrated dose-dependent improvements in itch severity and skin lesion clearance in patients with moderate to severe prurigo nodularis (PN), according to new results from a phase 2b randomized clinical trial. Res
- WISDOM Trial: Shaping the Future of Breast Cancer Screeninghttps://reachmd.com/news/wisdom-trial-breast-cancer-screening/2484974/The WISDOM trial showed that risk-based screening reduced occurrences of late-stage (≥IIB) screen-detected breast cancers compared with annual mammography while preserving overa